Skip to main navigation Skip to search Skip to main content

Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure

  • Christiane E. Angermann
  • , Carlos G. Santos-Gallego
  • , Juan Antonio Requena-Ibanez
  • , Susanne Sehner
  • , Tanja Zeller
  • , Louisa M.S. Gerhardt
  • , Christoph Maack
  • , Javier Sanz
  • , Stefan Frantz
  • , Valentin Fuster
  • , Georg Ertl
  • , Juan J. Badimon

Research output: Contribution to journal › Article › peer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science